Insider Transactions in Q3 2025 at Verve Therapeutics, Inc. (VERV)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 25
2025
|
Jason Politi Chief Technical Ops. Off. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
16,405
-100.0%
|
-
|
|
Jul 25
2025
|
Andrew D. Ashe |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
348,828
-100.0%
|
-
|
|
Jul 25
2025
|
Burt A Adelman |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
428,326
-100.0%
|
-
|
|
Jul 25
2025
|
Troy Lister Chief Scientific Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,952
-100.0%
|
-
|
|
Jul 25
2025
|
Sekar Kathiresan Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
351,994
-100.0%
|
-
|
|
Jul 25
2025
|
Sekar Kathiresan Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
348,431
-100.0%
|
-
|
|
Jul 25
2025
|
Joan Nickerson Chief Administrative Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
17,420
-100.0%
|
-
|
|
Jul 25
2025
|
Allison Dorval Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,280
-100.0%
|
-
|
|
Jul 25
2025
|
Krishna Yeshwant |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
12,168,489
-100.0%
|
-
|
|
Jul 25
2025
|
Gv 2017 Gp, L.L.C. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
12,168,489
-100.0%
|
-
|